『The Biotech Bargain: How Patents Help Turn Risk Into Medicine』のカバーアート

The Biotech Bargain: How Patents Help Turn Risk Into Medicine

The Biotech Bargain: How Patents Help Turn Risk Into Medicine

無料で聴く

ポッドキャストの詳細を見る
Do patents make drugs more expensive? And what role does intellectual property play in getting new medicines from the lab bench to patients?The questions have never been more timely. Biopharmaceutical innovation sits at the center of some of our biggest public policy debates. Drug pricing, access, generic competition, university research, venture funding, AI-driven discovery, follow-on research, and the future of biotech startups. And in the middle of those debates, patents are often reduced to slogans like patent monopolies and ever-greening and are assigned the political blame for high drug prices and limited patient access to medical breakthroughs. But the real system is much more complicated. Modern drug development is extraordinarily expensive, uncertain, regulated, and risky. A promising discovery may begin in a university lab, move through a startup, require venture financing, depend on partnerships with larger pharmaceutical companies, survive years of clinical testing, and then still face manufacturing approval, reimbursement, safety monitoring, and market adoption hurdles.Along that path, intellectual property is not just a prize at the end. It can be the asset that allows investment, collaboration, disclosure, licensing, specialization, and commercialization to happen in the first place. At the same time, the public has a legitimate interest in access, affordability, competition, and generic entry. So the policy challenge is understanding how the system works, what incentives are actually doing, and what can go wrong when lawmakers, courts, and pundits oversimplify the trade-offs.This is a big conversation, but the through line is simple. If we want more medicines, better medicines, and broader access to medicines, we need to understand the innovation system clearly before we start rewriting the rules.** Special Guest: Dr. Bo Heiden ** To help us truly understand the critical role of patent protections in the biopharmaceutical ecosystem and what prevailing narratives mean for investors, startups, and biotech R&D, we’re sitting down with Dr. Bo Heiden, one of the leading thinkers working at the intersection of intellectual property, innovation strategy, and life sciences policy. Dr. Heiden is the co-director of the Eira Initiative, a project out of the Berkeley Policy Institute, the Executive Director for the Tusher Strategic Initiative for Technology Leadership at Berkley’s Haas School of Business, the Co-Director of the Center for Intellectual Property (CIP) at University of Gothenburg, and the Co-Chair of the Technology, Innovation, and Intellectual Property program at the Classical Liberal Institute at the NYU School of Law.** Episode Overview **⦿ Drug price and access concerns, as they pertain to patents.⦿ The economic realities that make drug development a uniquely risky investment problem.⦿ The CliffsNotes history of why the modern biotech system emerged so strongly in the United States.⦿ What policymakers often miss in narratives around evergreening and patent monopolies, and how those narratives may now be pushing policy in directions that could undermine the very startup and R&D ecosystem we all depend on for advancements in medicine.⦿ The Supreme Court’s recent Hikma decision and what it means for skinny labels, induced infringement, and generic competition. ⦿ Practical takeaways on two of the hottest areas in the market: AI-driven drug discovery and the evolving GLP-1 regulatory and generic landscape.** Mossoff Minute: America's 250th and the Democratization of Invention **In this month's Mossoff Minute, Professor Adam Mossoff discusses the democratization of invention sparked by American independence.** Follow Aurora Patents **⦿ Home: https://www.aurorapatents.com/⦿ Twitter: https://twitter.com/AuroraPatents⦿ LinkedIn: https://www.linkedin.com/company/aurora-cg/⦿ Facebook: https://www.facebook.com/aurorapatents/⦿ Instagram: https://www.instagram.com/aurorapatents/ ⦿ TikTok: https://www.tiktok.com/@aurorapatents⦿ YouTube: https://www.youtube.com/@aurorapatents/Let us know what you think about this episode!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません